Apple, Oscar Health, Eli Lilly Hit 52-Week Highs on June 9; AAPL Reaches $317.40 on Siri AI Launch

On Monday (June 9), Apple (AAPL), Oscar Health (OSCR) and Eli Lilly (LLY) all reached 52-week highs amid developments in AI integration, business guidance and clinical trial results.

At its Worldwide Developers Conference, Apple unveiled Siri AI, a revamped assistant powered in part by Google Gemini technology, designed to work across Apple devices and handle complex tasks. AAPL stock reached an all-time high of $317.40 before closing down over 1% for the day. Oscar Health reaffirmed its 2026 revenue guidance of $18.7 billion to $19 billion, with OSCR hitting a five-year high of $27.59. Eli Lilly reported positive late-stage trial results for Foundayo, its oral obesity drug, showing stronger blood sugar control than competing treatments; LLY shares climbed to a record high of $1,182.73.